Noxafil and Neoplasm malignant - a phase IV clinical study of FDA data

Summary:

Neoplasm malignant is reported as a side effect among people who take Noxafil (posaconazole), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Venclexta, and have Acute myeloid leukaemia.

The phase IV clinical study analyzes which people have Neoplasm malignant when taking Noxafil. It is created by eHealthMe based on reports of 5,902 people who have side effects when taking Noxafil from the FDA, and is updated regularly.

What is Noxafil?

Noxafil has active ingredients of posaconazole. eHealthMe is studying from 5,919 Noxafil users. Check the latest studies of Noxafil.

What is Neoplasm malignant?

Neoplasm malignant (cancer tumour) is found to be associated with 1,535 drugs and 1,261 conditions by eHealthMe. Check the latest studies of Neoplasm malignant.

On Jul, 14, 2026

5,902 people reported to have side effects when taking Noxafil.
Among them, 19 people (0.32%) have Neoplasm malignant.

Among these 19 people:

How long have people been on Noxafil when they have Neoplasm malignant? *

What is the gender of people who have Neoplasm malignant when taking Noxafil? *

female: 31.25 %
male: 68.75 %

What is the age of people who have Neoplasm malignant when taking Noxafil? *

What are other drugs people take besides Noxafil? *

What are other side effects people have besides Neoplasm malignant? *

Death: 5 people, 26.32%
White Blood Cell Count Increased: 2 people, 10.53%
Cardiac Tamponade (fluid accumulates in heart covering): 2 people, 10.53%
Haemoglobin Decreased: 2 people, 10.53%
Haematocrit Decreased: 2 people, 10.53%
Gallbladder Oedema (swelling of gallbladder): 2 people, 10.53%
Fall: 2 people, 10.53%
Cholecystitis (infection of gallbladder): 2 people, 10.53%
Blood Urea Increased: 2 people, 10.53%
Heart Attack: 2 people, 10.53%

What are the existing conditions these people have? *

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 8 people, 42.11%
Type 2 Diabetes: 2 people, 10.53%
Nausea And Vomiting: 2 people, 10.53%
Nausea (feeling of having an urge to vomit): 2 people, 10.53%
Hypokalemia (low potassium): 2 people, 10.53%
Chronic Graft Versus Host Disease (immune cells attack the host's body cells after transplant): 2 people, 10.53%
Breast Cancer: 2 people, 10.53%
Hepatitis Viral: 1 person, 5.26%
Bacteraemia (presence of bacteria in the blood): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Noxafil and have Neoplasm malignant?

- Check whether Neoplasm malignant is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Noxafil:

Noxafil (5,919 reports)

Browse all side effects of Noxafil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Neoplasm malignant:

Neoplasm malignant (1,535 drugs)

Browse all the conditions that are associated with Neoplasm malignant:

Neoplasm malignant (1,261 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on posaconazole (the active ingredients of Noxafil) and Noxafil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.